Pipofezine, with the CAS number 24886-52-0, is an atypical antipsychotic medication primarily used in the treatment of various psychiatric disorders. It is characterized by its dual action as both a serotonin and dopamine receptor antagonist, which contributes to its efficacy in managing symptoms of schizophrenia and other mood disorders. The compound exhibits a relatively low affinity for muscarinic receptors, which helps minimize anticholinergic side effects commonly associated with other antipsychotics. Pipofezine is known for its sedative properties, making it beneficial for patients with agitation or insomnia related to their psychiatric conditions. Its pharmacokinetics involve oral administration, with a moderate half-life that allows for once or twice-daily dosing. As with many psychotropic medications, potential side effects may include weight gain, metabolic changes, and extrapyramidal symptoms, although these are generally less pronounced compared to typical antipsychotics. Overall, Pipofezine represents a valuable option in the pharmacological management of mental health disorders, particularly for patients who may not respond well to traditional treatments.

Pipofezine

24886-52-0: Pipofezine, with the CAS number 24886-52-0, is an atypical antipsychotic medication primarily used in the treatment of various psychiatric disorders. It is characterized by its dual action as both a serotonin and dopamine receptor antagonist, which contributes to its efficacy in managing symptoms of schizophrenia and other mood disorders. The compound exhibits a relatively low affinity for muscarinic receptors, which helps minimize anticholinergic side effects commonly associated with other antipsychotics. Pipofezine is known for its sedative properties, making it beneficial for patients with agitation or insomnia related to their psychiatric conditions. Its pharmacokinetics involve oral administration, with a moderate half-life that allows for once or twice-daily dosing. As with many psychotropic medications, potential side effects may include weight gain, metabolic changes, and extrapyramidal symptoms, although these are generally less pronounced compared to typical antipsychotics. Overall, Pipofezine represents a valuable option in the pharmacological management of mental health disorders, particularly for patients who may not respond well to traditional treatments.

CAS 24886-52-0

Pipofezine

Pipofezine

Ref: IN-DA002PPX

5-Methyl-3-(4-methylpiperazin-1-yl)-5H-benzo[b]pyridazino[4,3-e][1,4]oxazine

Ref: 10-F323911